ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Ep 21 | Thoughts on 340B & Biosimilar Uptake"
Episode Synopsis
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
More episodes of the podcast 340B Unscripted
Ep 79 | 340B Rebate Model Update
03/11/2025
Ep 77 | DSH Hospital Threats
29/09/2025
In God we trust